“increasing adoption of alternative and animal-free serum products”
- This shift is driven by ethical considerations, regulatory pressures, and advancements in cell culture technologies. Researchers and biopharmaceutical companies are exploring options like recombinant FBS and human-derived media to reduce reliance on animal-derived components and enhance reproducibility in cell-based assays.
- For instance, recombinant FBS, produced using genetically engineered cells, offers a safer and more ethical alternative to traditional FBS, aligning with the growing demand for sustainable and reproducible cell culture solutions .
